Literature DB >> 9188651

Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1- and NF-kappaB-binding sites of the interleukin-8 gene.

T Murayama1, Y Ohara, M Obuchi, K S Khabar, H Higashi, N Mukaida, K Matsushima.   

Abstract

Cytomegalovirus (CMV) infection induced interleukin-8 (IL-8) gene transcription in a human monocytic cell line, THP-1 cells, leading to IL-8 secretion. The functional analysis of the IL-8 gene revealed that both AP-1- and NF-kappaB factor-binding elements were involved in conferring the responsiveness to CMV. Moreover, electrophoretic mobility shift assays demonstrated that CMV induced the formation of NF-kappaB and AP-1 complexes. These results suggest that CMV activates these transcriptional factors, resulting in IL-8 gene expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188651      PMCID: PMC191819          DOI: 10.1128/JVI.71.7.5692-5695.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Human cytomegalovirus stimulates host cell RNA synthesis.

Authors:  S Tanaka; T Furukawa; S A Plotkin
Journal:  J Virol       Date:  1975-02       Impact factor: 5.103

2.  Growth characteristics of cytomegalovirus in human fibroblasts with demonstration of protein synthesis early in viral replication.

Authors:  T Furukawa; A Fioretti; S Plotkin
Journal:  J Virol       Date:  1973-06       Impact factor: 5.103

3.  Modulation of interleukin 1 beta gene expression by the immediate early genes of human cytomegalovirus.

Authors:  G K Iwamoto; M M Monick; B D Clark; P E Auron; M F Stinski; G W Hunninghake
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

4.  Increased monokines in cytomegalovirus infected myelomonocytic cell cultures.

Authors:  L W Turtinen; A Assimacopoulos; A T Haase
Journal:  Microb Pathog       Date:  1989-08       Impact factor: 3.738

5.  Establishment and characterization of a human acute monocytic leukemia cell line (THP-1).

Authors:  S Tsuchiya; M Yamabe; Y Yamaguchi; Y Kobayashi; T Konno; K Tada
Journal:  Int J Cancer       Date:  1980-08       Impact factor: 7.396

6.  Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products.

Authors:  G P Rice; R D Schrier; M B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

7.  Enhancement human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8.

Authors:  T Murayama; K Kuno; F Jisaki; M Obuchi; D Sakamuro; T Furukawa; N Mukaida; K Matsushima
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

8.  The precursor of NF-kappa B p50 has I kappa B-like functions.

Authors:  N R Rice; M L MacKichan; A Israël
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

9.  Repression of human cytomegalovirus major immediate early gene expression in a monocytic cell line.

Authors:  J H Sinclair; J Baillie; L A Bryant; J A Taylor-Wiedeman; J G Sissons
Journal:  J Gen Virol       Date:  1992-02       Impact factor: 3.891

10.  Regulation of expression of the IL-1 receptor antagonist (IL-1ra) gene by products of the human cytomegalovirus immediate early genes.

Authors:  J N Kline; L J Geist; M M Monick; M F Stinski; G W Hunninghake
Journal:  J Immunol       Date:  1994-03-01       Impact factor: 5.422

View more
  45 in total

1.  Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications.

Authors:  M C Cheeran; S Hu; S L Yager; G Gekker; P K Peterson; J R Lokensgard
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

2.  Circulating IgA from acute stage of childhood Henoch-Schönlein purpura can enhance endothelial interleukin (IL)-8 production through MEK/ERK signalling pathway.

Authors:  Y-H Yang; Y-H Huang; Y-L Lin; L-C Wang; Y-H Chuang; H-H Yu; Y-T Lin; B-L Chiang
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

3.  Assessment of reliability of microarray data and estimation of signal thresholds using mixture modeling.

Authors:  Musa H Asyali; Mohamed M Shoukri; Omer Demirkaya; Khalid S A Khabar
Journal:  Nucleic Acids Res       Date:  2004-04-27       Impact factor: 16.971

4.  Selection of AU-rich transiently expressed sequences: reversal of cDNA abundance.

Authors:  Khalid S A Khabar; Mohammed Dhalla; Latifa Al-Haj; Tala Bakheet; Cheikh Sy; Mohammed Naemmuddin
Journal:  RNA       Date:  2004-04       Impact factor: 4.942

5.  Human T-cell lymphotropic virus type 3: complete nucleotide sequence and characterization of the human tax3 protein.

Authors:  Sara Calattini; Sébastien Alain Chevalier; Renan Duprez; Philippe Afonso; Alain Froment; Antoine Gessain; Renaud Mahieux
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Human cytomegalovirus immediate-early 2 protein IE86 blocks virus-induced chemokine expression.

Authors:  R Travis Taylor; Wade A Bresnahan
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  Establishment of an in vitro system to study intracellular behavior of Candida glabrata in human THP-1 macrophages.

Authors:  Maruti Nandan Rai; Sapan Borah; Gaurav Bairwa; Sriram Balusu; Neelima Gorityala; Rupinder Kaur
Journal:  J Vis Exp       Date:  2013-12-10       Impact factor: 1.355

8.  Latent cytomegalovirus infection and innate immune function following a 75 km cycling time trial.

Authors:  Emily C P LaVoy; David C Nieman; Dru A Henson; R Andrew Shanely; Amy M Knab; Lynn Cialdella-Kam; Richard J Simpson
Journal:  Eur J Appl Physiol       Date:  2013-08-09       Impact factor: 3.078

Review 9.  Current Understanding of Cytomegalovirus Reactivation in Critical Illness.

Authors:  Hannah Imlay; Ajit P Limaye
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

10.  Induction of the RelB NF-kappaB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1 complexes.

Authors:  Xiaobo Wang; Gail E Sonenshein
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.